Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
17 04 2021
Historique:
received: 22 03 2021
revised: 08 04 2021
accepted: 16 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 19 8 2021
Statut: epublish

Résumé

The influenza A virus (IAV) is able to infect multiple mammalian and avian species, and in humans IAV is responsible for annual seasonal epidemics and occasional pandemics of respiratory disease with significant health and economic impacts. Studying IAV involves laborious secondary methodologies to identify infected cells. Therefore, to circumvent this requirement, in recent years, multiple replication-competent infectious IAV expressing traceable reporter genes have been developed. These IAVs have been very useful for in vitro and/or in vivo studies of viral replication, identification of neutralizing antibodies or antivirals, and in studies to evaluate vaccine efficacy, among others. In this report, we describe, for the first time, the generation and characterization of two replication-competent influenza A/Puerto Rico/8/1934 H1N1 (PR8) viruses where the viral non-structural protein 1 (NS1) was substituted by the monomeric (m)Cherry fluorescent or the NanoLuc luciferase (Nluc) proteins. The ΔNS1 mCherry was able to replicate in cultured cells and in Signal Transducer and Activator of Transcription 1 (STAT1) deficient mice, although at a lower extent than a wild-type (WT) PR8 virus expressing the same mCherry fluorescent protein (WT mCherry). Notably, expression of either reporter gene (mCherry or Nluc) was detected in infected cells by fluorescent microscopy or luciferase plate readers, respectively. ΔNS1 IAV expressing reporter genes provide a novel approach to better understand the biology and pathogenesis of IAV, and represent an excellent tool to develop new therapeutic approaches against IAV infections.

Identifiants

pubmed: 33920517
pii: v13040698
doi: 10.3390/v13040698
pmc: PMC8072579
pii:
doi:

Substances chimiques

INS1 protein, influenza virus 0
Viral Nonstructural Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI145332
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400005C
Pays : United States

Références

J Gen Virol. 2008 Oct;89(Pt 10):2359-2376
pubmed: 18796704
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
PLoS One. 2017 Nov 16;12(11):e0188267
pubmed: 29145498
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
Front Microbiol. 2019 Dec 17;10:2862
pubmed: 31921042
Arch Virol. 2015 Jul;160(7):1729-40
pubmed: 25959557
J Virol. 2017 Oct 27;91(22):
pubmed: 28835506
J Virol. 2019 Apr 3;93(8):
pubmed: 30728266
J Virol. 2012 Oct;86(19):10293-301
pubmed: 22787224
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
pubmed: 10801978
J Virol. 2015 Jul;89(13):6528-31
pubmed: 25878098
J Virol. 2020 Mar 17;94(7):
pubmed: 31941776
Pathogens. 2020 Mar 17;9(3):
pubmed: 32192196
J Virol. 2006 Apr;80(8):3957-65
pubmed: 16571812
Curr Opin Virol. 2020 Oct;44:26-34
pubmed: 32599532
J Virol. 2017 Feb 14;91(5):
pubmed: 28003482
Sci Rep. 2018 Mar 12;8(1):4374
pubmed: 29531320
Curr Opin Pharmacol. 2012 Oct;12(5):592-600
pubmed: 22954534
Cell. 1996 Feb 9;84(3):443-50
pubmed: 8608598
J Virol. 2004 Apr;78(8):3880-8
pubmed: 15047804
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4309-14
pubmed: 10725408
Virol J. 2013 Jul 25;10:243
pubmed: 23886034
J Virol. 2017 Aug 10;91(17):
pubmed: 28637754
PLoS One. 2014 May 19;9(5):e97695
pubmed: 24842154
Front Microbiol. 2018 Mar 29;9:559
pubmed: 29651275
J Virol. 2007 Jul;81(13):7011-21
pubmed: 17442719
J Virol. 2010 Dec;84(24):12761-70
pubmed: 20926573
Virology. 2020 Jun;545:16-23
pubmed: 32174455
Vaccine. 2007 Nov 19;25(47):7999-8009
pubmed: 17933442
Int J Mol Sci. 2016 Dec 22;18(1):
pubmed: 28025504
J Immunol. 2000 Apr 15;164(8):4220-8
pubmed: 10754318
mBio. 2014 May 13;5(3):e00070-14
pubmed: 24825008
Cold Spring Harb Perspect Med. 2020 Oct 1;10(10):
pubmed: 31871232
Virus Res. 2016 May 2;216:26-40
pubmed: 26220478
J Vis Exp. 2010 Aug 03;(42):
pubmed: 20729804
Trends Microbiol. 2014 Aug;22(8):446-55
pubmed: 24798745
J Virol. 2006 Nov;80(22):11009-18
pubmed: 16943300
Viruses. 2019 Feb 22;11(2):
pubmed: 30813325
Methods Mol Biol. 2017;1602:205-238
pubmed: 28508223
Arch Virol. 1995;140(5):945-50
pubmed: 7605205
J Virol. 2014 Sep;88(18):10778-91
pubmed: 25008914
Virology. 1998 Dec 20;252(2):324-30
pubmed: 9878611
J Virol. 2009 Feb;83(4):1742-53
pubmed: 19073731
Curr Opin Immunol. 2002 Aug;14(4):432-6
pubmed: 12088676
Curr Opin Virol. 2020 Oct;44:154-161
pubmed: 32932215
J Virol. 2014 Oct;88(20):12146-51
pubmed: 25078692
mBio. 2019 Mar 12;10(2):
pubmed: 30862743
PLoS One. 2016 Jun 07;11(6):e0156906
pubmed: 27272307
PLoS Pathog. 2012;8(12):e1003019
pubmed: 23236273
J Virol. 2005 Dec;79(24):15246-57
pubmed: 16306596
Viruses. 2018 Oct 15;10(10):
pubmed: 30326610
Viruses. 2015 Oct 13;7(10):5319-27
pubmed: 26473913
PLoS One. 2016 Jan 25;11(1):e0147723
pubmed: 26809059
J Virol. 2007 Sep;81(18):9727-36
pubmed: 17634232
Virus Res. 2016 Feb 2;213:69-81
pubmed: 26590325
J Virol. 2019 May 1;93(10):
pubmed: 30867298
Cell Rep. 2013 Jan 31;3(1):23-9
pubmed: 23333274
Virology. 2005 Oct 10;341(1):34-46
pubmed: 16084555
J Virol. 2005 Jul;79(13):8431-9
pubmed: 15956587
Viruses. 2018 Dec 12;10(12):
pubmed: 30545063
Cold Spring Harb Perspect Med. 2020 Jul 1;10(7):
pubmed: 31871237
J Gen Virol. 2005 Oct;86(Pt 10):2817-2821
pubmed: 16186237
J Virol. 2015 Mar;89(6):2990-4
pubmed: 25540375
Viruses. 2018 Aug 28;10(9):
pubmed: 30154345
Virology. 2015 Feb;476:206-216
pubmed: 25553516
J Virol. 2014 Sep;88(18):10525-40
pubmed: 24965472
Front Immunol. 2018 Apr 12;9:743
pubmed: 29755452
J Virol. 2018 Sep 12;92(19):
pubmed: 30021892
Cold Spring Harb Perspect Med. 2021 Mar 1;11(3):
pubmed: 31871226
J Virol. 2008 Nov;82(21):10580-90
pubmed: 18768976
Vet Microbiol. 2000 May 22;74(1-2):3-13
pubmed: 10799774
Vaccine. 2012 Jan 5;30(2):280-8
pubmed: 22067263
ACS Chem Biol. 2012 Nov 16;7(11):1848-57
pubmed: 22894855
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2002-7
pubmed: 12574509
Virology. 2017 Jan;500:1-10
pubmed: 27750071
Nature. 2019 Sep;573(7773):287-290
pubmed: 31485076
J Virol. 2018 Feb 12;92(5):
pubmed: 29237841
J Virol. 2016 Oct 14;90(21):9693-9711
pubmed: 27535054
Int Immunol. 2013 Dec;25(12):663-9
pubmed: 24158954
J Gen Virol. 2012 Aug;93(Pt 8):1645-1648
pubmed: 22535774
J Biomed Opt. 2005 Jul-Aug;10(4):41210
pubmed: 16178634
Pathogens. 2020 Jan 29;9(2):
pubmed: 32013198
Front Microbiol. 2018 Oct 24;9:2546
pubmed: 30405591
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11531-6
pubmed: 20534532
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74
pubmed: 22371588
Viruses. 2016 Jun 23;8(7):
pubmed: 27347991

Auteurs

Aitor Nogales (A)

Animal Health Research Centre (CISA), National Institute for Agriculture and Food Research and Technology (INIA), Valdeolmos, 28130 Madrid, Spain.

Michael Schotsaert (M)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Raveen Rathnasinghe (R)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Marta L DeDiego (ML)

Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, 28049 Madrid, Spain.

Adolfo García-Sastre (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Luis Martinez-Sobrido (L)

Texas Biomedical Research Institute, San Antonio, TX 78227, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH